Aldeyra Therapeutics
IPOMedicines to Treat Immune-Mediated Diseases | Aldeyra Therapeutics, Inc.
Public · Lexington, United States · $10.1M raised
- Headquarters
- Lexington, Massachusetts
- Employees
- 11–50
- Business Model
- B2B
- Website
- aldeyra.com
- Total Funding
- $10.1M
- Last Round
- $5.0M SeedJan 2013
- Rounds
- 2
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 3 funding rounds and 1 investor for this company. The full record is or through the API.
About
Aldeyra Therapeutics is a biotechnology company developing innovative therapies for immune-mediated diseases, including rare retinal conditions.
Summary
Aldeyra Therapeutics is a Biotech company based in Lexington, United States. It has raised $10.1M in total across 2 rounds, most recently a $5.0M Seed round in Jan 2013. Investors include Johnson & Johnson Innovation.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
May 2014
Sign up to see all 3 events
Funding: Seed. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/aldeyra-therapeutics"><img src="https://indexed.vc/api/badge/company/aldeyra-therapeutics" alt="Aldeyra Therapeutics on Indexed.vc" width="260" height="76" /></a>